Chesapeake PERL
Savage
About Chesapeake PERL
Chesapeake PERL, Inc., a biotechnology company, develops and produces proteins for biotechnology markets in the United States. It produces humanized glycoproteins and human therapeutics, including kinases, viral antigens, growth factors, and antibodies. The company manufactures proteins in non-glycosylated or contains insect glycan patterns. Its proteins are used in various applications, including therapeutics, diagnostics, industrial enzymes, agriculture, bioremediation, and biotechnology tools. The company was founded in 2000 and is based in Savage, Maryland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $265.0K
- Last round: Debt Financing (Jan 2010)
- Website: c-perl.com
- Phone: 3013179342
Industries & Categories
Biotechnology, Farming, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/chesapeake-perl-3250287 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.